Konaz Antifungal Cream contains Ketoconazole 2% w/w, a broad-spectrum antifungal agent effective against various dermatophytic infections and superficial mycoses. Ketoconazole belongs to the imidazole class of antifungals and acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Konaz Antifungal Cream is indicated for the treatment of cutaneous fungal infections such as tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor. It is also effective against seborrheic dermatitis caused by Malassezia species. The cream should be applied topically to the affected area once or twice daily, as directed by a healthcare professional, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. Patients are advised to clean and dry the affected area thoroughly before application and to avoid contact with eyes and mucous membranes. Adverse effects are generally mild and may include local irritation, burning sensation, or itching. Konaz Antifungal Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. Proper adherence to the prescribed regimen is essential to prevent recurrence and resistance.